Dose Comparison Study of Menactra® in US Children
Public ClinicalTrials.gov record NCT00700635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Exploratory Evaluation of a Two-dose Schedule Versus a One-dose Schedule of Menactra® (Meningococcal [Groups A, C, Y and W 135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) in Children in the US
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To explore the potential benefit of the administration of Menactra vaccine as a two-dose regimen to children. Primary Objective: To assess, by age group, the immune response to Menactra vaccine after each vaccine injection.
Study identification
- NCT ID
- NCT00700635
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 333 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 2 Years to 10 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2008 (Type not available)
- Primary completion
- May 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Apr 14, 2016
2008 – 2009
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Boca Raton | Florida | 33433 | — |
| Not listed | Viera | Florida | 32940 | — |
| Not listed | Woburn | Massachusetts | 01801 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Cleveland | Ohio | 44121 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Fort Worth | Texas | 76135 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | Orem | Utah | 84057 | — |
| Not listed | Midlothian | Virginia | 23113 | — |
| Not listed | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00700635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2016 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00700635 live on ClinicalTrials.gov.